Novo Nordisk (NVO) stock in focus as the company promotes FDA-approved Wegovy as a ban for makers of compounding versions ...

U.S. stocks are set to wrap a winning week as tariff and trade fears ease, President Trump winds down his Middle East trip ...

May 16 - As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the Atlantic for a leader deeply entrenched in the United States, by far its ...

Yahoo Finance host Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute, including Galaxy Digital's (GLXY) debut on the Nasdaq, Eli Lilly (LLY) getting a lift ...

Copenhagen (AFP) – Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday its chief executive was stepping down in the wake ...

Novo Nordisk CEO Lars Fruergaard Jorgensen is stepping down as competition in the weight-loss drug space pressured the company's stock. "Considering the recent market challenges, the share price ...

Novo Nordisk (NYSE: NVO) stock tumbled 3.9% through 10:45 a.m. ET this morning after the manufacturer of GLP-1 weight loss drugs announced its CEO, Lars Fruergaard Jørgensen, will step down from ...

Septerna's stock jumped 69% in premarket trading after the deal was announced. Novo Nordisk's stock rose 1.2% in European trading. May 30 (UPI) -- The Centers for Disease Control and Prevention is ...

Novo Nordisk’s (NVO) share price is down 54% from its peak in June 2024. Its US-listed shares fell another 3% in morning trading Friday. The company, headquartered in Bagsvaerd, Denmark ...

Novo Nordisk's share price is down 54% from its peak in June 2024. Its U.S.-listed shares fell another 3% in morning trading Friday. The company, headquartered in Bagsvaerd, Denmark, praised a ...

Eli Lilly funded the study. Novo Nordisk's share price is down 54% from its peak in June 2024. Its U.S.-listed shares fell another 3% in premarket trading Friday. The company, headquartered in ...